This is an antiproliferative miRNA that interferes with biological pathways that target genes involved in glioblastoma pathogenesis, including EGFR and platelet-derived growth factor receptor alpha (PDGFRA) [174], E2F3a [175], and WEE1 [176]. This evidence concerns the gene PDGFRA and glioblastoma.